Literature DB >> 12103464

Course and rate of antidepressant response in the very old.

Ariel G Gildengers1, Patricia R Houck, Benoit H Mulsant, Bruce G Pollock, Sati Mazumdar, Mark D Miller, Mary Amanda Dew, Ellen Frank, David J Kupfer, Charles F Reynolds.   

Abstract

OBJECTIVE: The authors examined elderly patients with major depression to determine the relationship of current age to treatment response course and success rate.
METHODS: Three studies of elderly depressed patients provided data on antidepressant treatment response in 323 subjects, treated in protocols using either nortriptyline or paroxetine. We grouped the subjects by current age: 'young-old' (59-69, N=163), 'middle-old' (70-75, N=80), and 'older-old' (76-99, N=80). We employed mixed-effect random regression analyses to examine Hamilton Rating Scale for Depression scores over 12 weeks of acute treatment.
RESULTS: Older-old patients responded as quickly and successfully as the young- and middle-old.
CONCLUSIONS: Major depression in the very old can be treated as successfully as in early old age.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12103464     DOI: 10.1016/s0165-0327(01)00334-2

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  10 in total

Review 1.  Use of antidepressants in older patients with co-morbid medical conditions: guidance from studies of depression in somatic illness.

Authors:  Gary J Kennedy; Paula Marcus
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Aging and emotion recognition: not just a losing matter.

Authors:  Jocelyn A Sze; Madeleine S Goodkind; Anett Gyurak; Robert W Levenson
Journal:  Psychol Aging       Date:  2012-07-23

3.  Empirically derived decision trees for the treatment of late-life depression.

Authors:  Carmen Andreescu; Benoit H Mulsant; Patricia R Houck; Ellen M Whyte; Sati Mazumdar; Alexandre Y Dombrovski; Bruce G Pollock; Charles F Reynolds
Journal:  Am J Psychiatry       Date:  2008-05-01       Impact factor: 18.112

Review 4.  Getting better, getting well: understanding and managing partial and non-response to pharmacological treatment of non-psychotic major depression in old age.

Authors:  Henry C Driscoll; Jordan F Karp; Mary Amanda Dew; Charles F Reynolds
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

5.  Risk factors for depressive disorders in very old age: a population-based cohort study with a 5-year follow-up.

Authors:  Sofia Petersson; Johan Mathillas; Karin Wallin; Birgitta Olofsson; Per Allard; Yngve Gustafson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-10-08       Impact factor: 4.328

Review 6.  Time course of response to antidepressants in late-life major depression: therapeutic implications.

Authors:  Ellen M Whyte; Mary Amanda Dew; Ariel Gildengers; Eric J Lenze; Ashok Bharucha; Benoit H Mulsant; Charles F Reynolds
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

7.  Rescue pharmacotherapy with duloxetine for selective serotonin reuptake inhibitor nonresponders in late-life depression: outcome and tolerability.

Authors:  Jordan F Karp; Ellen M Whyte; Eric J Lenze; Mary A Dew; Amy Begley; Mark D Miller; Charles F Reynolds
Journal:  J Clin Psychiatry       Date:  2008-03       Impact factor: 4.384

8.  Are old-old patients with major depression more likely to relapse than young-old patients during continuation treatment with escitalopram?

Authors:  Constantine G Lyketsos; Emmanuelle Weiller; Cornelius Katona; Phillip Gorwood
Journal:  BMC Geriatr       Date:  2011-01-14       Impact factor: 3.921

Review 9.  Treatment-resistant Late-life Depression: Challenges and Perspectives.

Authors:  Christian Knöchel; Gilberto Alves; Benedikt Friedrichs; Barbara Schneider; Anna Schmidt-Rechau; Sofia Wenzler; Angelina Schneider; David Prvulovic; André F Carvalho; Viola Oertel-Knöchel
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

10.  A Model Based Cost-Effectiveness Analysis of Routine Genotyping for CYP2D6 among Older, Depressed Inpatients Starting Nortriptyline Pharmacotherapy.

Authors:  Elizabeth J J Berm; Judith J Gout-Zwart; Jos Luttjeboer; Bob Wilffert; Maarten J Postma
Journal:  PLoS One       Date:  2016-12-29       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.